Viewing Study NCT00587457


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2025-12-31 @ 1:57 PM
Study NCT ID: NCT00587457
Status: TERMINATED
Last Update Posted: 2017-07-06
First Post: 2007-12-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia
Sponsor: MedImmune LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CAT-8015-1002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View